Lv4
450 积分 2021-10-14 加入
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial
4个月前
已完结
Radiothérapie et thérapies ciblées : risques et opportunités
4个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
4个月前
已完结
Zolbetuximab: First Approval
4个月前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
4个月前
已完结
Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer
5个月前
已完结
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
5个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
7个月前
已完结
80O Atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: Sub-analysis from the pivotal phase III IMpower010 study
8个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
11个月前
已完结
皖公网安备34019202002308
